SWISSRE瑞士再保险品牌怎么样 申请店铺

我要投票 SWISSRE瑞士再保险在保险行业中的票数:605 更新时间:2025-08-25
SWISSRE瑞士再保险是哪个国家的品牌?「SWISSRE瑞士再保险」是SWISSRE瑞士再保险旗下著名品牌。该品牌发源于瑞士,在1863年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力SWISSRE瑞士再保险品牌出海!将品牌入驻外推网,定制SWISSRE瑞士再保险品牌推广信息,可以显著提高SWISSRE瑞士再保险产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

SWISSRE瑞士再保险怎么样

瑞士再保险集团是一家领先的再保险、保险和其他保险型风险转移方式的批量业务提供商。集团以直接交易方式和通过经纪公司方式开展业务,全球客户群包括保险公司、大中型企业和公共部门客户。从标准产品乃至各个险种的量身定制保险保障,瑞士再保险都能充分利用其资本实力、专长和创新能力,以帮助承担企业和社会发展过程中的风险。

瑞士再保险于1863年在瑞士苏黎世创立,在风险保障、解决方案以及服务等方面声誉卓著。

瑞士再保险的策略是以可持续发展和盈利增长为核心,有效利用资本,重视与客户发展密切而互利的关系。公司的市场地位、业务多样性、资本实力、风险管理方法在保险界有口皆碑。

瑞再控股是瑞士再保险集团的控股公司,其记名股票根据瑞士证券交易所主要标准上市,并以股票代码“SREN”进行交易。瑞士再保险目前的评级为:(i)标准普尔:“AA-”级;(ii)穆迪:“Aa3”级;(iii)A.M.Best:“A+”级。

在亚太地区

瑞士再保险自1956年起就已在亚太地区开展业务,在中国、日本、韩国、新加坡、印度和澳大利亚等国家设有多个办事机构,公司在亚太地区的总部设在香港。

在中国

自中国保险市场对外开放以来,瑞士再保险成为首批进入中国市场的外国再保险公司之一。瑞士再保险先后于1995年和1996年分别在北京和上海设立了代表处,并于2003年12月19日正式成立北京分公司,在全国开展全面的产、寿险再保险业务。

瑞士再保险积极致力于通过研讨会等各种形式,和国内保险业界分享国际保险最新理念和经验。同时还在国内知名高等院校的保险系开办课程、提供资助,为中国保险业的发展做出贡献。

产品与服务

瑞士再保险提供全面的资本和风险管理产品,包括传统再保险和基于保险的企业融资方案,并针对全面风险管理提供辅助性服务。公司的核心再保险产品是为财产及意外险和人寿及健康险业务提供广泛的再保险保障和相关服务。


Swiss Re Group is a leading volume business provider of reinsurance, insurance and other insurance based risk transfer methods. The Group operates in the form of direct transactions and brokerage companies, and its global customer base includes insurance companies, large and medium-sized enterprises and public sector customers. From standard products to customized insurance guarantee of various types of insurance, Swiss Re can make full use of its capital strength, expertise and innovation ability to help bear the risks in the process of enterprise and social development. Swiss Re was founded in Zurich in 1863. It has a reputation for risk protection, solutions and services. Swiss Re's strategy is to take sustainable development and profit growth as the core, make effective use of capital, and pay attention to the close and mutually beneficial relationship with customers. The company's market position, business diversity, capital strength and risk management methods are well known in the insurance industry. Swiss Re holdings is the holding company of Swiss Re Group. Its registered shares are listed according to the main standards of Swiss stock exchange and are traded under the stock code "SREN". Swiss Re's current ratings are: (I) Standard & Poor's: "AA -"; (II) Moody's: "aa3"; and (III) a.m.best: "a +". Swiss Re has been operating in the Asia Pacific region since 1956. It has many offices in China, Japan, South Korea, Singapore, India, Australia and other countries. Its headquarters in the Asia Pacific region is located in Hong Kong. Since China's insurance market opened to the outside world, Swiss Re has become one of the first foreign reinsurance companies to enter the Chinese market. Swiss Re has set up representative offices in Beijing and Shanghai in 1995 and 1996 respectively, and formally established its Beijing Branch on December 19, 2003 to carry out comprehensive reinsurance business of property and life insurance in China. Swiss Re is actively committed to sharing the latest international insurance concepts and experiences with the domestic insurance industry through seminars and other forms. At the same time, it also provides courses and financial support to the insurance departments of well-known colleges and universities in China to contribute to the development of China's insurance industry. Products and services Swiss Re provides comprehensive capital and risk management products, including traditional reinsurance and insurance based corporate financing solutions, as well as supporting services for comprehensive risk management. The company's core reinsurance products are to provide a wide range of reinsurance protection and related services for property and casualty and life and health insurance businesses.

本文链接: https://brand.waitui.com/f5f9c75dc.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

格林美:筹划发行H股股票并在香港联交所上市

36氪获悉,格林美发布公告,经充分研究论证,董事会同意公司发行H股股票并在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。公司将充分考虑现有股东的利益和境内外资本市场的情况,在股东会决议有效期内(即经公司股东会审议通过之日起24个月或同意延长的其他期限)选择适当的时机和发行窗口完成本次发行上市。截至目前,公司正积极与相关中介机构就本次发行上市的相关工作进行商讨,除本次董事会、监事会审议通过的相关议案外,其他关于本次发行上市的具体细节尚未最终确定。

2小时前

中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元

36氪获悉,中信证券研报表示,创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求,改变前列腺癌诊疗范式,实现诊疗一体化,提高患者依从性和生存期。目前中国尚无任何RDC上市,市场呈现蓝海状态,海外前列腺癌RDC诊疗产品在2021年上市,2024年市场已接近30亿美元,充分验证了其巨大的商业价值。中信证券认为中国有望复刻海外前列腺癌RDC诊疗市场发展路径,预计未来中国前列腺癌RDC诊疗市场将超100亿元,市场呈现高速增长状态。该行业关键点为核素、配体分子形态、生产配送能力,建议关注在上述条件具有优势的公司。

2小时前

​锡业股份:上半年净利润10.62亿元,同比增长32.76%

36氪获悉,锡业股份披露2025年半年报,上半年实现营业收入210.93亿元,同比增长12.35%;归属于上市公司股东的净利润10.62亿元,同比增长32.76%;基本每股收益0.626元。

2小时前

亚世光电:上半年净利润538.04万元,同比下降36.21%

36氪获悉,亚世光电披露2025年半年报,上半年实现营业收入4.32亿元,同比增长30.01%;归属于上市公司股东的净利润538.04万元,同比下降36.21%;基本每股收益0.0331元。

2小时前

金螳螂:上半年净利润3.58亿元,同比增长3.95%

36氪获悉,金螳螂披露2025年半年报,上半年实现营业收入95.28亿元,同比增长2.49%;归属于上市公司股东的净利润3.58亿元,同比增长3.95%;基本每股收益0.1348元。

2小时前

本页详细列出关于SWISSRE瑞士再保险的品牌信息,含品牌所属公司介绍,SWISSRE瑞士再保险所处行业的品牌地位及优势。
咨询